Home

PHARMACEUTICAL COMPANY FOCUSED ON CANNABIS FOR THE BETTERMENT OF MANKIND

PHARMACEUTICAL COMPANY FOCUSED ON CANNABIS FOR THE BETTERMENT OF MANKIND

Mandara Pharma is deeply committed to delivering safe, effective, high-quality products for consumers by meeting the highest pharmaceutical standards for cannabinoid-based products.

Mandara Pharma combines novel technology platforms with targeted cannabis genetics.

Pharmaceutical Heritage - Our Unique Strength

genetics and cultivation

Genetics & Cultivation

Our expertise in genetics positions Mandara Pharma for dramatic growth and builds our value.

We own a broad range of 213 high-/low-producing CBD and THC strains developed in our genetics labs in Colombia and Spain and registered in Colombia.

Ten of the CBD-dominant strains have received PEAs registration in Colombia allowing them to be cultivated, extracted, and transported for international use.

This ownership is unique in the industry and enables us to create any customized strain we require.

Products and Brands

Product Development

Once a cannabinoid profile has been matched to a disease or condition and the strains have been registered, the product development process begins.

  1. Analytical characterization to verify the cannabinoid profile
  2. Formulation development including specialized delivery systems
  3. Non-clinical studies in animals
  4. Clinical trials in humans – Phase I to III
  5. Regulatory submission
Transformation

Quality, Manufacturing, Compliance

At Mandara Pharma, we promote a culture of Quality across all of our activities.

From seed to sale, Mandara Pharma operations are carried out under a strict quality control system.

Social Entrepreneurship

Commercialization

Our senior leadership has extensive experience in bringing pharmaceutical products from conception through production to market.

  1. Sell or license our drug products (clinical trial-based) to global pharmaceutical companies.
  2. Sell or license our API to pharma companies and R&D companies and they will conduct clinical trials and bring the new therapies to market.
  3. Well-positioned to be an international supplier of high-quality medical-grade products.

Global Operations

  •  

    USA

    Mandara Pharma Inc. has entered into a strategic partnership with MandaraRx (formerly known as BoomRx), a cannabis sales and distribution company headquartered in Boulder, Colorado.

  •  

    Colombia

    Through Mandara Pharma Colombia S.A.S. and strategic alliances, genetics, cultivation, GMP extraction and R&D programs are in operation in Roldanillo, Valle del Cauca and the Latin American headquarters in Cali.

    Fully-licensed cultivation capacity of 1.9M sq. ft. in Colombia – ideal climate and growing conditions at very low cost.

  •  

    Spain

    Through Mandara Pharma Spain S.L., a European corporate office has been established in Parc Scientific, University Politechnical of Valencia (UPV) to develop genetic strains and development of in-vitro tissue culture and micropropagation techniques.

  •  

    Canada

    Mandarapharma Inc. is a registered company in Ontario, Canada. It specializes in the cannabis-based pharmaceutical industry, holding licenses in Colombia for the cultivation, extraction, transformation, transport and export of both psychoactive and non-psychoactive cannabis plants.

 

Our global footprint helps us develop pharmaceutical-grade cannabis extractions, while encouraging social entrepreneurship that benefits the communities where we work.

 

 

About Us
 

Reach Out To Us

Learn how we set the standards for cannabis-based pharmaceutical industry. For more information about investment opportunities, please contact us. We want to meet you.

Mandara Pharma is committed to cultivating Nature’s nurturing plant for the betterment of mankind.

Connect